Gennex Laboratories Cash Flow Annual

Trade
BSE: 531739 | NSE: - | ISIN: INE509C01026 | Sector: Biotechnology & Drugs
19.47 +0.26 (1.35%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 16.496.375.285.06
Depreciation/ Depletion 2.370.920.790.88
Non- Cash Items -0.72-1.311.780.69
Changesin Working Capital -64.8317.694.07-8.07
Cashfrom Operating Activities -46.6923.6811.91-1.44
Capital Expenditures 0.00-39.79-1.59-0.08
Other Investing Cash Flow Items Total 18.911.46-0.870.05
Cashfrom Investing Activities 18.91-38.33-2.47-0.02
Financing Cash Flow Items -3.08-1.35-0.88-0.74
Issuance( Retirement)of Stock Net 79.8330.440.00-
Issuance( Retirement)of Debt Net -3.07-8.05-0.952.36
Cashfrom Financing Activities 73.6821.03-1.831.62
Net Changein Cash 45.916.387.610.16
Cash Interest Paid 3.081.350.880.74
Cash Taxes Paid -0.001.111.53
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts